abstract |
The present invention provides N,N(2-methyl-5-hydroxyphenyl)-(6-methanesulfonyl-quinolin-4-yl)-amine which exhibits protein tyrosine kinase inhibition, in particular p56lck activity, method(s) for its preparation, pharmaceutical compositions containing it and its use in medicine. |